Cytokinetics reported $133.2M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Acorda Therapeutics ACOR:US USD 38.5M 6.47M
Amgen AMGN:US USD 3.91B 504M
Arca Biopharma ABIO:US USD 5.68M 1.58M
Bayer BAYN:GR EUR 10.08B 2.57B
Biogen BIIB:US USD 1.19B 1.45B
Brainstorm Cell Therapeutics BCLI:US USD 6.84M 750K
Bristol Myers Squibb BMY:US USD 8.75B 552M
Capricor Therapeutics CAPR:US USD 8.07M 747.57K
Cytokinetics CYTK:US USD 133.2M 33.36M
Eisai 4523:JP JPY 176.54B 283M
Eli Lilly And LLY:US USD 5.27B 12.8M
Exelixis EXEL:US USD 329.12M 6.6M
Geron GERN:US USD 40.24M 12.2M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Intra Cellular Therapies ITCI:US USD 127.5M 16M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Merk MRK:US USD 10.97B 1.31B
Novartis NOVN:VX USD 10.67B 183M
Pfizer PFE:US USD 13.23B 2.41B
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Roche Holding ROG:VX 20.75B 3.26B